EyePoint (EYPT) Non Operating Investment Income (2011 - 2017)
EyePoint (EYPT) reported Non Operating Investment Income of $1000.0 for Q1 2017, down 88.89% on a YoY basis from $9000.0 in Q1 2016, and little changed sequentially from $1000.0 in Q3 2016.
EyePoint (EYPT) Non Operating Investment Income (2011 - 2017) Analysis & Trends
EyePoint (EYPT) has 7 years of Non Operating Investment Income data on file, last reported at $1000.0 in Q1 2017.
- For the quarter ending Q1 2017, Non Operating Investment Income fell 88.89% year-over-year to $1000.0; the trailing twelve-month figure through Dec 2016 stood at $8000.0 (up 366.67% YoY), and the FY2016 full-year result was $3000.0, up 175.0% from the prior year.
- Non Operating Investment Income held at $1000.0 in Q1 2017, from $1000.0 in the prior quarter.
- In the past five years, Non Operating Investment Income ranged from a high of $9000.0 in Q1 2016 to a low of -$6000.0 in Q4 2015.
- A 5-year average of $416.67 and a median of $1000.0 in 2014 frame the typical range for Non Operating Investment Income.
- Across the five-year window, Non Operating Investment Income slumped 200.0% in 2015 and surged 800.0% in 2016, its largest moves.
- Tracing EYPT's Non Operating Investment Income over 5 years: stood at $4000.0 in 2013, then tumbled by 150.0% to -$2000.0 in 2014, then tumbled by 200.0% to -$6000.0 in 2015, then soared by 116.67% to $1000.0 in 2016, then changed by 0.0% to $1000.0 in 2017.
- Business Quant data shows EYPT's Non Operating Investment Income at $1000.0 in Q1 2017, $1000.0 in Q3 2016, and -$2000.0 in Q2 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | EyePoint | 1.07 Mn | -221.48 Mn | 168,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2017 | 1,000.00 |
| Mar 31, 2017 | 1,000.00 |
| Sep 30, 2016 | 1,000.00 |
| Sep 30, 2016 | 1,000.00 |
| Jun 30, 2016 | -2,000.00 |
| Jun 30, 2016 | -2,000.00 |
| Mar 31, 2016 | 9,000.00 |
| Mar 31, 2016 | 9,000.00 |
| Dec 31, 2015 | -6,000.00 |
| Dec 31, 2015 | -6,000.00 |
| Sep 30, 2015 | 2,000.00 |
| Sep 30, 2015 | 2,000.00 |
| Mar 31, 2015 | 1,000.00 |
| Mar 31, 2015 | 1,000.00 |
| Dec 31, 2014 | -2,000.00 |
| Dec 31, 2014 | -2,000.00 |
| Sep 30, 2014 | -3,000.00 |
| Sep 30, 2014 | -3,000.00 |
| Jun 30, 2014 | 1,000.00 |
| Jun 30, 2014 | 1,000.00 |